Eli Lilly and Company Total Liabilities 2011-2026 | LLY

Annual Total Liabilities Eli Lilly and Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	36.6 B	33 B	33.3 B	24.7 B	21 B	21.8 B	17.6 B	19.6 B	20.1 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.6 B	17.6 B	25.3 B

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Veracyte VCYT	96.4 M	$ 30.92	-5.73 %	$ 2.43 B	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	7.24 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	110 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Atreca BCEL	76.6 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	425 M	-	-	$ 546 M	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Avid Bioservices CDMO	276 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	288 M	$ 12.67	-9.24 %	$ 1.92 B	USA
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	4.18 B	$ 321.51	-2.03 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	68.8 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	140 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	4.1 M	$ 1.09	-	$ 22.4 M	Israel
Enochian Biosciences ENOB	29.6 M	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Equillium EQ	3.29 M	$ 1.91	-7.28 %	$ 109 M	USA
Amphastar Pharmaceuticals AMPH	840 M	$ 19.46	-0.36 %	$ 910 M	USA
Amarin Corporation plc AMRN	211 M	$ 14.23	-2.97 %	$ 5.91 B	Irlanda
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	343 M	$ 45.99	-3.28 %	$ 4.14 B	Schweiz
Arbutus Biopharma Corporation ABUS	18 M	$ 4.33	-2.81 %	$ 830 M	Canada
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	6.5 M	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	34.2 M	-	-	$ 384 M	Britain
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA